Dycom Industries Business Sale Proceeds increased by 10.9% to $2.79M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 74.4%, from $10.90M to $2.79M. Over 4 years (FY 2022 to FY 2026), Business Sale Proceeds shows an upward trend with a 58.2% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.04M | $1.19M | $991.00K | $137.00K | $5.38M | $3.46M | $5.66M | $2.89M | $9.31M | $11.01M | $10.21M | $4.71M | $12.70M | $9.53M | $8.19M | $8.72M | $10.90M | $12.60M | $7.63M | $2.51M | $2.79M |
| QoQ Change | — | -60.9% | -16.8% | -86.2% | >999% | -35.7% | +63.7% | -49.0% | +222.7% | +18.2% | -7.3% | -53.9% | +169.9% | -25.0% | -14.1% | +6.5% | +25.0% | +15.6% | -39.5% | -67.0% | +10.9% |
| YoY Change | — | — | — | — | +76.6% | +190.1% | +470.7% | >999% | +73.2% | +218.6% | +80.4% | +63.0% | +36.4% | -13.5% | -19.8% | +85.4% | -14.2% | +32.2% | -6.9% | -71.2% | -74.4% |